Patrick John Finn - Dec 2, 2021 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
Chief Commercial Officer
Signature
/s/ William Solis, as Attorney-in-Fact for Patrick John Finn
Stock symbol
TWST
Transactions as of
Dec 2, 2021
Transactions value $
-$108,709
Form type
4
Date filed
12/6/2021, 03:35 PM
Previous filing
Nov 23, 2021
Next filing
Dec 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Options Exercise $40.4K +1.52K +3.97% $26.66 39.8K Dec 2, 2021 Direct
transaction TWST Common Stock Options Exercise $5.62K +241 +0.61% $23.33 40K Dec 2, 2021 Direct
transaction TWST Common Stock Sale -$102K -1.17K -2.93% $87.06 38.8K Dec 2, 2021 Direct F1
transaction TWST Common Stock Sale -$52.7K -586 -1.51% $90.00 38.2K Dec 2, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -1.52K -4.17% $0.00 34.9K Dec 2, 2021 Common Stock 1.52K $26.66 Direct F2
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -241 -1.18% $0.00 20.2K Dec 2, 2021 Common Stock 241 $23.33 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 3, 2020.
F2 20% of the shares subject to the option vested and became exercisable on October 31, 2019, and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F3 25% of the shares subject to the option vested and became exercisable on October 24, 2020, and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.